Latest filing published 28 May 2018 for Wilson Therapeutics AB, €160k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew Kay: trading record in brief
Andrew Kay is a declared insider of Wilson Therapeutics AB, with filings sourced from Finansinspektionen. Altogether 2 filings, all relating to 25 May 2018.
On the open market, the record shows 1 purchase worth €160k and 1 sale worth €160k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 29 May 2018 came the latest disclosure, an open-market sale for €160k in Wilson Therapeutics AB. The last purchase on record was published on 28 May 2018, which is 3,086 days ago. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Andrew Kay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,088 shares@ SEK 232.00100.0% of flowISIN SE0008293674FI:csv-051ba1ee57d02670b373Canonical exit: 23 Aug 2018 (T+90)
1 of 1 declaration